Access cutting-edge schizophrenia treatment through this clinical trial at a research site in Gaithersburg. Study-provided care at no cost to qualified participants.
Access schizophrenia specialists in Gaithersburg at no cost
This study follows strict safety protocols and ethical guidelines
All study-related schizophrenia treatment provided free
Schizophrenia is a common and severe psychiatric illness characterized by extreme disturbances of cognition and thought, affecting language, perception and sense of self. This study will assess adverse events, change in disease activity, and how oral emraclidine moves through the body in adult participants with schizophrenia Emraclidine is an investigational drug being developed for the treatment of schizophrenia. Participants are placed in one of two parts, Part A or Part B, where each group w
Sponsor: AbbVie
Check if you qualify for this schizophrenia clinical trial in Gaithersburg, MD
If you're searching for schizophrenia treatment options in Gaithersburg, MD, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Gaithersburg research site is actively enrolling participants for this clinical trial. You'll receive care from experienced schizophrenia specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.